image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 4.15
-8.99 %
$ 1.58 B
Market Cap
-103.75
P/E
1. INTRINSIC VALUE

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.[ Read More ]

The intrinsic value of one GDRX stock under the base case scenario is HIDDEN Compared to the current market price of 4.15 USD, GoodRx Holdings, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart GDRX

image
FINANCIALS
750 M REVENUE
-2.12%
-27 M OPERATING INCOME
-245.25%
-8.87 M NET INCOME
72.99%
138 M OPERATING CASH FLOW
-5.78%
-55.8 M INVESTING CASH FLOW
73.51%
-167 M FINANCING CASH FLOW
-39.23%
195 M REVENUE
-2.67%
20.4 M OPERATING INCOME
-1.02%
3.96 M NET INCOME
-40.77%
86.9 M OPERATING CASH FLOW
795.39%
-15.9 M INVESTING CASH FLOW
7.95%
-172 M FINANCING CASH FLOW
-19822.34%
Balance Sheet Decomposition GoodRx Holdings, Inc.
image
Current Assets 873 M
Cash & Short-Term Investments 672 M
Receivables 160 M
Other Current Assets 40.4 M
Non-Current Assets 716 M
Long-Term Investments 15 M
PP&E 45.9 M
Other Non-Current Assets 655 M
Current Liabilities 123 M
Accounts Payable 36.3 M
Short-Term Debt 21.1 M
Other Current Liabilities 65.2 M
Non-Current Liabilities 704 M
Long-Term Debt 696 M
Other Non-Current Liabilities 8.18 M
EFFICIENCY
Earnings Waterfall GoodRx Holdings, Inc.
image
Revenue 750 M
Cost Of Revenue 66.9 M
Gross Profit 683 M
Operating Expenses 710 M
Operating Income -27 M
Other Expenses -18.1 M
Net Income -8.87 M
RATIOS
91.08% GROSS MARGIN
91.08%
-3.60% OPERATING MARGIN
-3.60%
-1.18% NET MARGIN
-1.18%
-1.16% ROE
-1.16%
-0.56% ROA
-0.56%
-0.30% ROIC
-0.30%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis GoodRx Holdings, Inc.
image
Net Income -8.87 M
Depreciation & Amortization 112 M
Capital Expenditures -55.8 M
Stock-Based Compensation 105 M
Change in Working Capital -21.9 M
Others 5.14 M
Free Cash Flow 82.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets GoodRx Holdings, Inc.
image
Wall Street analysts predict an average 1-year price target for GDRX of $9.5 , with forecasts ranging from a low of $9 to a high of $10 .
GDRX Lowest Price Target Wall Street Target
9 USD 116.87%
GDRX Average Price Target Wall Street Target
9.5 USD 128.92%
GDRX Highest Price Target Wall Street Target
10 USD 140.96%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership GoodRx Holdings, Inc.
image
Sold
0-3 MONTHS
30.3 K USD 1
3-6 MONTHS
535 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
983 K USD 1
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Sep 03, 2024
Sell 30.3 K USD
Spectrum Equity VII, L.P.
10 percent owner
- 3849
7.8601 USD
3 months ago
Aug 12, 2024
Sell 535 K USD
Nabiey Romin
Chief Accounting Officer
- 79000
6.7674 USD
11 months ago
Nov 30, 2023
Bought 125 K USD
Wagner Scott
See Remarks
+ 21652
5.7642 USD
11 months ago
Nov 29, 2023
Bought 155 K USD
Wagner Scott
See Remarks
+ 26348
5.9011 USD
11 months ago
Nov 28, 2023
Bought 24.9 K USD
Wagner Scott
See Remarks
+ 4157
5.9996 USD
1 year ago
Nov 17, 2023
Bought 140 K USD
Wagner Scott
See Remarks
+ 26664
5.2607 USD
1 year ago
Nov 16, 2023
Bought 537 K USD
Wagner Scott
See Remarks
+ 104079
5.1615 USD
2 years ago
Jan 03, 2022
Sell 85.9 K USD
Idea Men, LLC
10 percent owner
- 2600
33.049 USD
2 years ago
Jan 03, 2022
Sell 694 K USD
Slutsky Andrew
President, Consumer
- 21625
32.1003 USD
2 years ago
Jan 03, 2022
Sell 467 K USD
Slutsky Andrew
President, Consumer
- 14204
32.8518 USD
2 years ago
Dec 28, 2021
Sell 413 K USD
Voermann Karsten
Chief Financial Officer
- 12500
33.0546 USD
2 years ago
Dec 22, 2021
Sell 2.26 M USD
Bezdek Trevor
Co-CEO
- 64271
35.1875 USD
2 years ago
Dec 23, 2021
Sell 2.21 M USD
Bezdek Trevor
Co-CEO
- 65104
33.9823 USD
2 years ago
Dec 20, 2021
Sell 1.13 M USD
Abdiel Capital Management, LLC
10 percent owner
- 34566
32.75 USD
2 years ago
Dec 20, 2021
Sell 35.7 K USD
Abdiel Capital Management, LLC
10 percent owner
- 1089
32.75 USD
2 years ago
Dec 20, 2021
Sell 3.61 M USD
Abdiel Capital Management, LLC
10 percent owner
- 107847
33.48 USD
2 years ago
Dec 20, 2021
Sell 114 K USD
Abdiel Capital Management, LLC
10 percent owner
- 3398
33.48 USD
2 years ago
Dec 21, 2021
Sell 2.13 M USD
Abdiel Capital Management, LLC
10 percent owner
- 60000
35.5 USD
2 years ago
Dec 15, 2021
Sell 1.37 M USD
Abdiel Capital Management, LLC
10 percent owner
- 38735
35.28 USD
2 years ago
Dec 15, 2021
Sell 2.2 M USD
Abdiel Capital Management, LLC
10 percent owner
- 60400
36.41 USD
2 years ago
Dec 16, 2021
Sell 95.2 K USD
Abdiel Capital Management, LLC
10 percent owner
- 2800
33.99 USD
2 years ago
Dec 16, 2021
Sell 5.25 M USD
Abdiel Capital Management, LLC
10 percent owner
- 152034
34.55 USD
2 years ago
Dec 16, 2021
Sell 1.65 M USD
Abdiel Capital Management, LLC
10 percent owner
- 46563
35.44 USD
2 years ago
Dec 16, 2021
Sell 1.76 M USD
Abdiel Capital Management, LLC
10 percent owner
- 48603
36.18 USD
2 years ago
Dec 17, 2021
Sell 1.97 M USD
Abdiel Capital Management, LLC
10 percent owner
- 58271
33.77 USD
2 years ago
Dec 17, 2021
Sell 160 K USD
Abdiel Capital Management, LLC
10 percent owner
- 4752
33.77 USD
2 years ago
Dec 17, 2021
Sell 3.44 M USD
Abdiel Capital Management, LLC
10 percent owner
- 99241
34.65 USD
2 years ago
Dec 17, 2021
Sell 280 K USD
Abdiel Capital Management, LLC
10 percent owner
- 8093
34.65 USD
2 years ago
Dec 17, 2021
Sell 123 K USD
Abdiel Capital Management, LLC
10 percent owner
- 3501
35.08 USD
2 years ago
Dec 17, 2021
Sell 10 K USD
Abdiel Capital Management, LLC
10 percent owner
- 286
35.08 USD
2 years ago
Dec 15, 2021
Sell 713 K USD
Hirsch Douglas Joseph
Co-CEO
- 20125
35.4282 USD
2 years ago
Dec 15, 2021
Sell 1.55 M USD
Hirsch Douglas Joseph
Co-CEO
- 42437
36.5575 USD
2 years ago
Dec 15, 2021
Sell 1.93 M USD
Hirsch Douglas Joseph
Co-CEO
- 51363
37.6382 USD
2 years ago
Dec 15, 2021
Sell 406 K USD
Hirsch Douglas Joseph
Co-CEO
- 10550
38.4731 USD
2 years ago
Dec 15, 2021
Sell 194 K USD
Hirsch Douglas Joseph
Co-CEO
- 4900
39.4938 USD
2 years ago
Dec 09, 2021
Sell 154 K USD
Azad Babak
See Remarks
- 3770
40.9582 USD
2 years ago
Dec 09, 2021
Sell 356 K USD
Azad Babak
See Remarks
- 8430
42.1862 USD
2 years ago
Dec 09, 2021
Sell 12.8 K USD
Azad Babak
See Remarks
- 300
42.68 USD
2 years ago
Dec 08, 2021
Sell 474 K USD
Slutsky Andrew
President, Consumer
- 12072
39.2777 USD
2 years ago
Dec 08, 2021
Sell 1.07 M USD
Slutsky Andrew
President, Consumer
- 26631
40.306 USD
2 years ago
Dec 08, 2021
Sell 5.21 M USD
Slutsky Andrew
President, Consumer
- 126297
41.2768 USD
2 years ago
Dec 01, 2021
Sell 3.77 M USD
Idea Men, LLC
10 percent owner
- 98072
38.4036 USD
2 years ago
Dec 01, 2021
Sell 1.96 M USD
Idea Men, LLC
10 percent owner
- 49983
39.3129 USD
2 years ago
Dec 03, 2021
Sell 3.34 M USD
Idea Men, LLC
10 percent owner
- 89231
37.3905 USD
2 years ago
Dec 02, 2021
Sell 2.35 M USD
Idea Men, LLC
10 percent owner
- 61722
38.0659 USD
2 years ago
Dec 03, 2021
Sell 1.94 M USD
Idea Men, LLC
10 percent owner
- 50855
38.1958 USD
2 years ago
Dec 02, 2021
Sell 1.77 M USD
Idea Men, LLC
10 percent owner
- 45529
38.9723 USD
2 years ago
Dec 01, 2021
Sell 3.17 M USD
Idea Men, LLC
10 percent owner
- 78844
40.151 USD
2 years ago
Dec 02, 2021
Sell 374 K USD
Idea Men, LLC
10 percent owner
- 9422
39.7321 USD
2 years ago
Dec 03, 2021
Sell 1.02 M USD
Idea Men, LLC
10 percent owner
- 26122
38.9818 USD
2 years ago
Dec 01, 2021
Sell 161 K USD
Voermann Karsten
Chief Financial Officer
- 4189
38.3496 USD
2 years ago
Dec 01, 2021
Sell 86.5 K USD
Voermann Karsten
Chief Financial Officer
- 2200
39.3068 USD
2 years ago
Dec 01, 2021
Sell 246 K USD
Voermann Karsten
Chief Financial Officer
- 6111
40.2198 USD
3 years ago
Nov 09, 2021
Sell 493 K USD
Azad Babak
See Remarks
- 11700
42.1659 USD
3 years ago
Nov 09, 2021
Sell 34.5 K USD
Azad Babak
See Remarks
- 800
43.125 USD
3 years ago
Nov 01, 2021
Sell 542 K USD
Voermann Karsten
Chief Financial Officer
- 12300
44.0374 USD
3 years ago
Nov 01, 2021
Sell 0 USD
Voermann Karsten
Chief Financial Officer
- 200
0 USD
3 years ago
Nov 03, 2021
Sell 559 K USD
Idea Men, LLC
10 percent owner
- 12911
43.3091 USD
3 years ago
Nov 03, 2021
Sell 1.98 M USD
Idea Men, LLC
10 percent owner
- 44629
44.4486 USD
3 years ago
Nov 02, 2021
Sell 2.86 M USD
Idea Men, LLC
10 percent owner
- 67377
42.3924 USD
3 years ago
Nov 01, 2021
Sell 3 M USD
Idea Men, LLC
10 percent owner
- 68141
44.024 USD
3 years ago
Nov 02, 2021
Sell 711 K USD
Idea Men, LLC
10 percent owner
- 16573
42.9025 USD
3 years ago
Nov 03, 2021
Sell 4.46 M USD
Idea Men, LLC
10 percent owner
- 98592
45.2293 USD
3 years ago
Nov 02, 2021
Sell 3.28 K USD
Idea Men, LLC
10 percent owner
- 75
43.75 USD
3 years ago
Nov 01, 2021
Sell 85.1 K USD
Idea Men, LLC
10 percent owner
- 1900
44.7668 USD
3 years ago
Oct 22, 2021
Sell 186 K USD
Slutsky Andrew
President, Consumer
- 4050
45.9775 USD
3 years ago
Oct 22, 2021
Sell 749 K USD
Slutsky Andrew
President, Consumer
- 15950
46.9334 USD
3 years ago
Oct 19, 2021
Sell 4.5 K USD
NAGJI BANSI
President, Healthcare
- 100
45.02 USD
3 years ago
Oct 20, 2021
Sell 734 K USD
NAGJI BANSI
President, Healthcare
- 16300
45 USD
3 years ago
Oct 11, 2021
Sell 307 K USD
Azad Babak
See Remarks
- 7500
40.9117 USD
3 years ago
Oct 07, 2021
Sell 162 K USD
NAGJI BANSI
President, Healthcare
- 3600
45.0519 USD
3 years ago
Sep 30, 2021
Sell 6.45 M USD
Idea Men, LLC
10 percent owner
- 157254
41.0454 USD
3 years ago
Sep 30, 2021
Sell 428 K USD
Idea Men, LLC
10 percent owner
- 10303
41.5482 USD
3 years ago
Oct 01, 2021
Sell 162 K USD
Slutsky Andrew
President, Consumer
- 3900
41.5487 USD
3 years ago
Oct 01, 2021
Sell 580 K USD
Slutsky Andrew
President, Consumer
- 13669
42.4465 USD
3 years ago
Oct 01, 2021
Sell 548 K USD
Slutsky Andrew
President, Consumer
- 12555
43.6743 USD
3 years ago
Oct 01, 2021
Sell 216 K USD
Slutsky Andrew
President, Consumer
- 4894
44.2159 USD
3 years ago
Sep 28, 2021
Sell 282 K USD
Voermann Karsten
Chief Financial Officer
- 7000
40.2198 USD
3 years ago
Sep 28, 2021
Sell 20.8 K USD
Voermann Karsten
Chief Financial Officer
- 500
41.516 USD
3 years ago
Sep 29, 2021
Sell 4.84 M USD
Idea Men, LLC
10 percent owner
- 121197
39.9494 USD
3 years ago
Sep 27, 2021
Sell 9.24 M USD
Idea Men, LLC
10 percent owner
- 215756
42.8254 USD
3 years ago
Sep 28, 2021
Sell 11.4 M USD
Idea Men, LLC
10 percent owner
- 284254
40.1509 USD
3 years ago
Sep 28, 2021
Sell 1.18 M USD
Idea Men, LLC
10 percent owner
- 28787
41.0099 USD
3 years ago
Sep 27, 2021
Sell 3.27 M USD
Idea Men, LLC
10 percent owner
- 75488
43.3456 USD
3 years ago
Sep 29, 2021
Sell 5.93 M USD
Idea Men, LLC
10 percent owner
- 145529
40.782 USD
3 years ago
Sep 28, 2021
Sell 415 K USD
Idea Men, LLC
10 percent owner
- 9900
41.9255 USD
3 years ago
Sep 24, 2021
Sell 5.16 M USD
Hirsch Douglas Joseph
Co-CEO
- 116557
44.2401 USD
3 years ago
Sep 24, 2021
Sell 279 K USD
Hirsch Douglas Joseph
Co-CEO
- 6165
45.2994 USD
3 years ago
Sep 24, 2021
Sell 32.3 K USD
Hirsch Douglas Joseph
Co-CEO
- 700
46.1843 USD
3 years ago
Sep 27, 2021
Sell 234 K USD
Hirsch Douglas Joseph
Co-CEO
- 5452
42.9498 USD
3 years ago
Sep 27, 2021
Sell 21.8 K USD
Hirsch Douglas Joseph
Co-CEO
- 500
43.566 USD
3 years ago
Sep 24, 2021
Sell 5.16 M USD
Bezdek Trevor
Co-CEO
- 116558
44.2365 USD
3 years ago
Sep 24, 2021
Sell 313 K USD
Bezdek Trevor
Co-CEO
- 6912
45.2371 USD
3 years ago
Sep 24, 2021
Sell 41.5 K USD
Bezdek Trevor
Co-CEO
- 900
46.1004 USD
3 years ago
Sep 27, 2021
Sell 198 K USD
Bezdek Trevor
Co-CEO
- 4604
42.951 USD
3 years ago
Sep 27, 2021
Sell 17.4 K USD
Bezdek Trevor
Co-CEO
- 400
43.5825 USD
3 years ago
Sep 22, 2021
Sell 619 K USD
Slutsky Andrew
President, Consumer
- 13600
45.5213 USD
3 years ago
Sep 22, 2021
Sell 287 K USD
Slutsky Andrew
President, Consumer
- 6200
46.2187 USD
3 years ago
Sep 22, 2021
Sell 9.41 K USD
Slutsky Andrew
President, Consumer
- 200
47.05 USD
3 years ago
Sep 14, 2021
Sell 1.13 M USD
Slutsky Andrew
President, Consumer
- 25000
45.001 USD
3 years ago
Sep 15, 2021
Sell 209 K USD
REY-GIRAUD AGNES
Director
- 4637
45.0283 USD
3 years ago
Sep 14, 2021
Sell 650 K USD
REY-GIRAUD AGNES
Director
- 14454
45.0022 USD
3 years ago
Sep 16, 2021
Sell 266 K USD
REY-GIRAUD AGNES
Director
- 5909
45.0052 USD
3 years ago
Sep 16, 2021
Sell 1.34 M USD
NAGJI BANSI
President, Healthcare
- 29788
45.0345 USD
3 years ago
Sep 15, 2021
Sell 2.72 M USD
NAGJI BANSI
President, Healthcare
- 60415
45.0288 USD
3 years ago
Sep 14, 2021
Sell 4.04 M USD
NAGJI BANSI
President, Healthcare
- 89797
45.0129 USD
3 years ago
Sep 09, 2021
Sell 72.8 K USD
Azad Babak
See Remarks
- 1801
40.4217 USD
3 years ago
Sep 09, 2021
Sell 141 K USD
Azad Babak
See Remarks
- 3400
41.4212 USD
3 years ago
Sep 09, 2021
Sell 310 K USD
Azad Babak
See Remarks
- 7299
42.5266 USD
3 years ago
Sep 10, 2021
Bought 20.9 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 500
41.87 USD
3 years ago
Sep 09, 2021
Bought 3.72 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 90
41.3 USD
3 years ago
Sep 09, 2021
Bought 74.8 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 1810
41.3 USD
3 years ago
Sep 09, 2021
Bought 2.69 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 67
40.15 USD
3 years ago
Sep 09, 2021
Bought 53.5 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 1333
40.15 USD
3 years ago
Sep 09, 2021
Bought 200 USD
Abdiel Capital Management, LLC
10 percent owner
+ 5
39.94 USD
3 years ago
Sep 09, 2021
Bought 3.79 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 95
39.94 USD
3 years ago
Sep 07, 2021
Sell 2.26 M USD
REY-GIRAUD AGNES
Director
- 54370
41.5612 USD
3 years ago
Sep 08, 2021
Bought 31.2 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 754
41.42 USD
3 years ago
Sep 08, 2021
Bought 1 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 24205
41.42 USD
3 years ago
Sep 08, 2021
Bought 72.7 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 1792
40.55 USD
3 years ago
Sep 08, 2021
Bought 2.33 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 57524
40.55 USD
3 years ago
Sep 08, 2021
Bought 71.8 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 1801
39.84 USD
3 years ago
Sep 08, 2021
Bought 2.3 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 57821
39.84 USD
3 years ago
Sep 07, 2021
Bought 182 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 4357
41.69 USD
3 years ago
Sep 07, 2021
Bought 5.86 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 140643
41.69 USD
3 years ago
Sep 03, 2021
Bought 31.3 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 744
42.02 USD
3 years ago
Sep 03, 2021
Bought 1.01 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 23993
42.02 USD
3 years ago
Sep 03, 2021
Bought 141 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 3387
41.51 USD
3 years ago
Sep 03, 2021
Bought 4.54 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 109261
41.51 USD
3 years ago
Sep 03, 2021
Bought 45.6 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 1125
40.55 USD
3 years ago
Sep 03, 2021
Bought 1.47 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 36275
40.55 USD
3 years ago
Sep 03, 2021
Bought 11.3 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 284
39.93 USD
3 years ago
Sep 03, 2021
Bought 366 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 9167
39.93 USD
3 years ago
Sep 02, 2021
Bought 3.8 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 100
38 USD
3 years ago
Sep 01, 2021
Bought 12.7 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 334
37.92 USD
3 years ago
Sep 01, 2021
Bought 1.35 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 35535
37.92 USD
3 years ago
Aug 31, 2021
Bought 7.11 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 187
38 USD
3 years ago
Aug 31, 2021
Bought 228 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 6001
38 USD
3 years ago
Aug 31, 2021
Bought 745 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 19937
37.39 USD
3 years ago
Aug 31, 2021
Bought 24 M USD
Abdiel Capital Management, LLC
10 percent owner
+ 641702
37.39 USD
3 years ago
Aug 31, 2021
Bought 1.77 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 48
36.97 USD
3 years ago
Aug 31, 2021
Bought 57.4 K USD
Abdiel Capital Management, LLC
10 percent owner
+ 1552
36.97 USD
7. News
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, GoodRx insiders caused the company to misrepresent or fail to disclose that (1) while Kroger accounted for less than 5% of the pharmacies accepting GoodRx discounts, Kroger was responsible for nearly 25% of GoodRx's total prescription transactions revenue (the Company's primary revenue stream); and (2) Kroger could unilaterally cease accepting GoodRx discounts, cutting off some or all of GoodRx's revenues for purchases at Kroger's pharmacies; and (3) as a result, representations about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. prnewswire.com - 3 days ago
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX) on behalf of long-term stockholders following a class action complaint that was filed against GoodRx on April 22, 2024 with a Class Period from September 23, 2020, to November 8, 2022. Our investigation concerns whether the board of directors of GoodRx have breached their fiduciary duties to the company. globenewswire.com - 4 days ago
Why GoodRx Holdings Stock Was Sinking This Week The company is growing key fundamentals. However, the improvements weren't enough to impress the market. fool.com - 1 week ago
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript seekingalpha.com - 1 week ago
GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 1 week ago
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago. zacks.com - 1 week ago
GoodRx Reports Third Quarter 2024 Results SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income1 of $31.9 million; Adjusted Net Income Margin1 of 16.4% Adjusted EBITDA1 of $65.0 million; Adjusted. businesswire.com - 1 week ago
GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates Beyond analysts' top -and-bottom-line estimates for GoodRx (GDRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024. zacks.com - 1 week ago
GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement Smaller pharmacies are accusing GoodRx and CVS of colluding to suppress generic prescription drug reimbursements. As Reuters reported Tuesday (Nov. 5), drug coupon aggregator GoodRx and a pair of pharmacy benefit managers (PBMs) — CVS's Caremark unit and Express Scripts — have all been named in at least three lawsuits by independent pharmacies. pymnts.com - 1 week ago
GoodRx to Participate in Upcoming Investor Conferences SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 12, 2024 at 2 p.m. Eastern Time (11 a.m. Pacific Time) Citi 2024 Global Healthcare Conference in Miami, FL, on Thursday,. businesswire.com - 1 week ago
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX) breached their fiduciary duties to shareholders. globenewswire.com - 2 weeks ago
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies SANTA MONICA, Calif.--(BUSINESS WIRE)--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone therapies by Pfizer. Through the reach and scale of the GoodRx platform, these programs are broadening access and affordability of crucial medications for women. New research from GoodRx shows menopause medications have increased in list price by 58% since 2014. And according to a recent study,. businesswire.com - 3 weeks ago
8. Profile Summary

GoodRx Holdings, Inc. GDRX

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.58 B
Dividend Yield 0.00%
Description GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Contact 2701 Olympic Boulevard, Santa Monica, CA, 90404 https://www.goodrx.com
IPO Date Sept. 23, 2020
Employees 694
Officers Mr. Romin Nabiey Chief Accounting Officer Mr. Mike Walsh President & Executive Vice President of Prescription Marketplace Ms. Aubrey Reynolds Director of Investor Relations Mr. Scott W. Wagner Interim Chief Executive Officer & Principal Operating Officer Mr. Nitin Shingate Chief Technology Officer Mr. Bansi Nagji President of Healthcare Mr. Karsten Ian Voermann Chief Financial Officer Ms. Gracye Cheng General Counsel & Secretary Mr. Trevor Bezdek Co-founder & Chairman of the Board Mr. Douglas Joseph Hirsch Co-founder, Chief Mission Officer & Director